Market Overview:
The global HDL cholesterol market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of cardiovascular diseases, increasing awareness about the benefits of HDL cholesterol, and technological advancements in diagnostic instruments. Based on type, the global HDL cholesterol market is segmented into regents, instruments, and others. The regents segment is further sub-segmented into immunoassays and chromatography systems. The instruments segment is further sub-segmented into spectrophotometers and nephelometers. Based on application, the global HDL cholesterol market is divided into hospitals and clinics. Geographically, the global HDL cholesterol market has been classified into North America, Latin America, Europe Asia Pacific (APAC), and Middle East & Africa (MEA).
Product Definition:
HDL Cholesterol is a type of cholesterol that is found in the blood. HDL Cholesterol helps to remove bad cholesterol from the body. This can help to lower the risk of heart disease.
Regents:
Regents, also known as high-density lipoprotein cholesterol or high-Density Lipoprotein (HDL) cholesterol is a type of fat that helps to remove bad cholesterol from the body. HDL assists in removing toxins from the body by transporting them to the liver for processing and removal. The main function of HDL is to assist in removing excess bad cholesterol from arteries.
Instruments:
Instruments and it's usage in the HDL cholesterol market are used for measuring, detecting, analyzing or determining high density lipoprotein (HDL) cholesterol levels in biological fluids such as blood. The measurement of HDL-C is important because having a higher level of HDL-C reduces the risk of cardiovascular diseases.
Application Insights:
The application segment includes hospitals and clinics. In 2015, the hospital segment dominated the global market with a share of over 70% in terms of revenue. The growing prevalence of diseases such as cardiovascular disease, high blood pressure levels and diabetes is expected to drive the demand for new diagnostic tools and drugs that can treat these diseases at their early stages. This will result in increased expenditure on research & development activities by various companies active in this space which will fuel growth during the forecast period.
Increasing awareness about preventive healthcare among individuals is expected to boost spending on visits & treatments at wellness centers which further supports market growth during the forecast period. Moreover, increasing investments by governments to improve public health infrastructure including hospitals, clinics and wellness centers are anticipated to augment industry size during this period.
Regional Analysis:
North America dominated the global HDL cholesterol market in 2017. The region is expected to maintain its position during the forecast period owing to high prevalence of cardiovascular diseases and increasing adoption of preventive measures, such as diet modification and physical activity. In addition, rising awareness regarding risk factors associated with heart diseases is anticipated to propel regional growth over the forecast period.
Asia Pacific region is expected to witness lucrative growth over the forecast period due to improving economic conditions in emerging countries like India and China.
Growth Factors:
- Increasing awareness about the benefits of HDL cholesterol in preventing heart diseases is expected to drive the market growth.
- Rising prevalence of cardiovascular diseases is another major factor that would fuel the demand for HDL cholesterol products over the forecast period.
- Growing geriatric population is also anticipated to create lucrative opportunities for market players in near future.
- Technological advancements in diagnostic and therapeutic procedures are likely to boost demand for HDL cholesterol products significantly over next few years
Scope Of The Report
Report Attributes
Report Details
Report Title
HDL Cholesterol Market Research Report
By Type
Regents, Instruments, Others
By Application
Hospitals, Clinics
By Companies
Beckman Coulter, Alere North America, Alfa Wassermann, Elitechgroup, Jant Pharmacal Corporation, Medtest Dx, Pointe Scientific Inc, Polymer Technology Systems, Randox Laboratories, Verichem Laboratories Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global HDL Cholesterol Market Report Segments:
The global HDL Cholesterol market is segmented on the basis of:
Types
Regents, Instruments, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beckman Coulter
- Alere North America
- Alfa Wassermann
- Elitechgroup
- Jant Pharmacal Corporation
- Medtest Dx
- Pointe Scientific Inc
- Polymer Technology Systems
- Randox Laboratories
- Verichem Laboratories Inc
Highlights of The HDL Cholesterol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Regents
- Instruments
- Others
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HDL Cholesterol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the key players operating in the hdl cholesterol market are Beckman Coulter, Alere North America, Alfa Wassermann, Elitechgroup, Jant Pharmacal Corporation, Medtest Dx, Pointe Scientific Inc, Polymer Technology Systems, Randox Laboratories, Verichem Laboratories Inc.
The hdl cholesterol market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HDL Cholesterol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HDL Cholesterol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HDL Cholesterol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HDL Cholesterol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HDL Cholesterol Market Size & Forecast, 2018-2028
4.5.1 HDL Cholesterol Market Size and Y-o-Y Growth
4.5.2 HDL Cholesterol Market Absolute $ Opportunity
Chapter 5 Global HDL Cholesterol Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 HDL Cholesterol Market Size Forecast by Type
5.2.1 Regents
5.2.2 Instruments
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global HDL Cholesterol Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 HDL Cholesterol Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HDL Cholesterol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HDL Cholesterol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America HDL Cholesterol Analysis and Forecast
9.1 Introduction
9.2 North America HDL Cholesterol Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America HDL Cholesterol Market Size Forecast by Type
9.6.1 Regents
9.6.2 Instruments
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America HDL Cholesterol Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe HDL Cholesterol Analysis and Forecast
10.1 Introduction
10.2 Europe HDL Cholesterol Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe HDL Cholesterol Market Size Forecast by Type
10.6.1 Regents
10.6.2 Instruments
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe HDL Cholesterol Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific HDL Cholesterol Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific HDL Cholesterol Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific HDL Cholesterol Market Size Forecast by Type
11.6.1 Regents
11.6.2 Instruments
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific HDL Cholesterol Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America HDL Cholesterol Analysis and Forecast
12.1 Introduction
12.2 Latin America HDL Cholesterol Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America HDL Cholesterol Market Size Forecast by Type
12.6.1 Regents
12.6.2 Instruments
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America HDL Cholesterol Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) HDL Cholesterol Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) HDL Cholesterol Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) HDL Cholesterol Market Size Forecast by Type
13.6.1 Regents
13.6.2 Instruments
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) HDL Cholesterol Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HDL Cholesterol Market: Competitive Dashboard
14.2 Global HDL Cholesterol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beckman Coulter
14.3.2 Alere North America
14.3.3 Alfa Wassermann
14.3.4 Elitechgroup
14.3.5 Jant Pharmacal Corporation
14.3.6 Medtest Dx
14.3.7 Pointe Scientific Inc
14.3.8 Polymer Technology Systems
14.3.9 Randox Laboratories
14.3.10 Verichem Laboratories Inc
